- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of severe COVID-19: an evolving paradigm
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-5
Publisher
Informa UK Limited
Online
2022-10-22
DOI
10.1080/14656566.2022.2140041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Janus kinase inhibitor (baricitinib) suppresses the rheumatoid arthritis active marker gliostatin/thymidine phosphorylase in human fibroblast-like synoviocytes
- (2022) Yuji Joyo et al. IMMUNOLOGIC RESEARCH
- The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
- (2022) Melanie D. Whittington et al. VALUE IN HEALTH
- Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab: comentario
- (2022) Ismael Francisco Aomar-Millán et al. Reumatologia Clinica
- Treatment strategies of COVID-19: A rheumatology perspective
- (2022) Alexandros A. Drosos et al. European Journal of Internal Medicine
- The immunology and immunopathology of COVID-19
- (2022) Miriam Merad et al. SCIENCE
- BARICITINIB ATTENUATES THE PROINFLAMMATORY PHASE OF COVID-19 DRIVEN BY LUNG-INFILTRATING MONOCYTES
- (2022) Brian Dobosh et al. Cell Reports
- Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study
- (2022) Bill J Wright et al. Lancet Respiratory Medicine
- Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
- (2022) Wendao Li et al. Frontiers in Immunology
- Cytokine storm promoting T cell exhaustion in severe COVID-19 revealed by single cell sequencing data analysis
- (2022) Minglei Yang et al. Precision Clinical Medicine
- Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
- (2022) Daniele Zama et al. ANNALS OF HEMATOLOGY
- COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes
- (2022) Germaine Wong et al. TRANSPLANTATION
- COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
- (2022) Sarah E. Conway et al. Multiple Sclerosis and Related Disorders
- Can Obesity Prevalence Explain COVID-19 Indicators (Cases, Mortality, and Recovery)? A Comparative Study in OECD Countries
- (2022) Yuval Arbel et al. Journal of Obesity
- Baseline Thrombocytopenia and Disease Severity Among COVID-19 Patients, Tibebe Ghion Specialized Hospital COVID-19 Treatment Center, Northwest Ethiopia
- (2022) Fikir Asrie et al. Journal of Blood Medicine
- Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia
- (2022) Ruth Alex et al. Advances in Virology
- Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
- (2021) Rogan A. Grant et al. NATURE
- Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
- (2021) Viviane C Veiga et al. BMJ-British Medical Journal
- Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis
- (2021) Xiaobo He et al. Frontiers in Public Health
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- 2020 Year in Review: Pharmacologic Treatments for COVID-19
- (2021) Jessica L. Saunders et al. Respiratory Care
- Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
- (2021) Patrícia O. Guimarães et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study
- (2021) Gianluca Russo et al. PLoS One
- Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis
- (2021) Stephen E. Congly et al. Scientific Reports
- Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic
- (2021) Naim Mahroum et al. International Journal of Environmental Research and Public Health
- Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
- (2021) Vincent C Marconi et al. Lancet Respiratory Medicine
- In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support–free days
- (2021) Anthony A. Donato ANNALS OF INTERNAL MEDICINE
- Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells
- (2021) Mario Witkowski et al. NATURE
- Treatment of Persistent Erythema Multiforme With Janus Kinase Inhibition and the Role of Interferon Gamma and Interleukin 15 in Its Pathogenesis
- (2021) Michael J. Murphy et al. JAMA Dermatology
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
- (2020) Luca Carsana et al. LANCET INFECTIOUS DISEASES
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions
- (2020) Tapan Behl et al. LIFE SCIENCES
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Exploring the multifocal therapeutic approaches in COVID-19: A ray of hope
- (2020) Arun Kumar et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP)
- (2014) Kazuya Shirato et al. Virology Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More